Ikuya Seki

This inventor holds 9 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Nihon Medi-Physics Company, Limited, Kyoto University. Active years: 1998-2018.

USPTO Granted Patents = 9 (Patent Applications = 1)

% Patents Active = 33.3

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 26(Granted Patents)

Location History:

Chiba, JP (1998)
Ichihara, JP (1998)
Sodegaura, JP (2007 - 2010)
Tokyo, JP (2013 - 2018)

Company Filing History:

9 out of 142

Nihon Medi-Physics Company, Limited

where one patent can have more than one assignee

Years Active: 1998-2018

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10081630 - Radioactive halogen-labeled pyrido [1,2-A] benzimidazole derivative compound (2018-09-25),

2. 10080812 - Radioactive iodine labeled pyrido[1,2-a]benzoimidazole derivative compound (2018-09-25),

3. 9044520 - Compound accumulating in inflammatory site, diagnostic agent containing the compound in labeled state and its precursor compound for labeling (2015-06-02),

4. 8476449 - Radioactive iodine labeled organic compound or salt thereof (2013-07-02),

5. 7854918 - Composition for medical use having improved water-solubility of peptide and metal-labeling efficiency and preparation for medical use comprising metal-labeled peptide (2010-12-21),

6. 7220827 - Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient (2007-05-22),

7. 5827498 - Tumor affinity peptide, and radioactive diagnostic agent and radioactive (1998-10-27),

8. 5785948 - Metal chelate forming peptides and use thereof represented by three (1998-07-28),

9. 5770178 - Metal chelate forming peptides and use thereof (1998-06-23),

Title: Ikuya Seki: Innovator in Radiopharmaceuticals

Introduction

Ikuya Seki is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of radiopharmaceuticals, holding a total of nine patents. His work focuses on developing innovative compounds that have potential applications in medical imaging and treatment.

Latest Patents

Among his latest patents is a radioactive iodine-labeled pyrido[1,2-a]benzoimidazole derivative compound. This invention relates to a compound represented by a specific general formula or a salt thereof, which can be utilized in radiopharmaceuticals. Another notable patent is for a radioactive halogen-labeled pyrido[1,2-a]benzimidazole derivative compound. This invention also pertains to a compound represented by a specific general formula or a salt thereof, intended for use in radiopharmaceuticals.

Career Highlights

Ikuya Seki has worked with notable organizations such as Nihon Medi-Physics Company, Limited and Kyoto University. His experience in these institutions has allowed him to advance his research and development in the field of radiopharmaceuticals.

Collaborations

He has collaborated with esteemed colleagues, including Yoshifumi Shirakami and Hideo Saji. These partnerships have contributed to the success of his innovative projects.

Conclusion

Ikuya Seki's work in the field of radiopharmaceuticals showcases his dedication to advancing medical science through innovation. His patents reflect a commitment to developing compounds that can significantly impact healthcare.